Immix Biopharma, Inc. (IMMX) Balance Sheet
As of 2026-06-30 (10-Q), Immix Biopharma, Inc. (IMMX) reported total assets of $239.1M, total liabilities of $10.2M and shareholders' equity of $228.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $225.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IMMXImmix Biopharma, Inc.Follow IMMX — free
—
Price chart with a free account
- Market cap
- 583.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.4 | 17.6 | 13.4 | 17.5 | 17.7 | 93.9 | 225.5 | |
| Short-term investments | — | — | — | — | — | 6.5 | 6.6 | |
| Current assets | 0.5 | 18.2 | 14.9 | 19.8 | 20.2 | 101.2 | 233.8 | |
| Total assets | 0.5 | 18.2 | 14.9 | 19.9 | 22.9 | 104.8 | 239.1 | |
| Current liabilities | 5.3 | 0.2 | 1.3 | 3.7 | 8.7 | 10.1 | 9.3 | |
| Total liabilities | 5.3 | 0.2 | 1.7 | 3.7 | 9.7 | 11.0 | 10.2 | |
| Shareholders' equity | -4.7 | 18.0 | 13.2 | 16.2 | 13.3 | 93.8 | 228.9 |
USD millions · SEC XBRL
Immix Biopharma, Inc. — questions
- How much cash does Immix Biopharma, Inc. have?
- $225.5M in cash and cash equivalents as of 2026-06-30.
- What are Immix Biopharma, Inc.'s total assets?
- $239.1M as of 2026-06-30.
- What is Immix Biopharma, Inc.'s shareholders' equity?
- $228.9M as of 2026-06-30.
Every figure on this page comes from Immix Biopharma, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.